Back to News
Market Impact: 0.2
Liquidia Settles All Litigation With United Therapeutics; Shares Rise
Source: Nasdaq
Legal & LitigationHealthcare & Biotech
Liquidia Corp. and United Therapeutics Corp. entered into a global settlement agreement resolving all six pending litigation matters between them. The article provides no settlement terms or financial impact.
AllMind Terminal
AI-powered research, real-time alerts, and portfolio analytics for institutional investors.
Request TrialMarket Sentiment
Overall Sentiment
neutral
Sentiment Score
0.05
Ticker Sentiment
LQDA0.55
UTHR0.55
More News
- Liquidia shares surge 25% as settlement ends United Therapeutics litigation
- US Stocks Tumble as Chip Rout Deepens
- Bank of America Has 'Accountability' in Face of Fines, Says Moynihan
- OpenAI bugging suspect allegedly booked one-way trip to Saudi Arabia
- Travis Kelce joined an activist group pushing Six Flags to consider a sale. The ‘Final Destination’-style death of a patron poured gas on the fire
- WiseTech shares surge as ASIC drops action against founder White